Font Size:
a
A
A
Keyword [anti-angiogenic inhibitors]
Result: 1 - 1 | Page: 1 of 1
1.
The Mechanisms Underlying The Synergistic Antitumor Activity Of Multi-targeted Tyrosine Kinase Inhibitor Famitinib And The Third-generation EGFR Inhibitor HS-10296 As Well As The Antitumor Activity Of The Novel Antibody-drug Conjugates Targeting CD79b
<<First
<Prev Next>
Last>>
Jump to
